or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    STAA C -3.18 2.11
    ISRG B -0.91 1.93
    AXGN B 1.86 1.88
    GH C -1.59 1.84
    NTRA B 0.85 1.80
    ARWR C -0.59 1.79
    VRTX B -0.74 1.78
    BSX B -0.57 1.77
    SYK C -0.68 1.77
    REGN B -1.97 1.75
    CRL F -0.03 1.75
    TMO D 0.31 1.72
    DHR D -0.17 1.69
    CTLT B 0.55 1.68
    EW B -0.16 1.66
    ILMN F -0.22 1.63
    INCY C -2.30 1.62
    IQV F -0.32 1.61
    PEN F 0.81 1.61
    IART C -1.58 1.59
    CRSP F 1.48 1.53
    A D 0.28 1.52
    NOVT C 0.00 1.52
    IRTC D -1.88 1.51
    MEDP C -0.33 1.50
    BIO F 0.94 1.50
    AZTA D 0.82 1.49
    VCYT C 0.99 1.48
    ALNY A 0.43 1.47
    GEHC D 1.19 1.46
    ABT D -0.84 1.45
    DXCM F -1.40 1.45
    HOLX C -0.07 1.45
    EXAS F 0.05 1.43
    QGEN D -0.29 1.43
    MRNA D -0.96 1.40
    UTHR B -1.90 1.40
    ALGN D 1.51 1.37
    FLGT F -0.25 1.33
    BMRN D -1.51 1.30
    TWST C 1.44 1.30
    CDNA B -0.07 1.30
    BMY F -0.96 1.29
    MASI F 0.66 1.29
    GMED A 0.84 1.27
    BDX F -0.17 1.26
    NVCR D 0.42 1.25
    OMCL F 2.29 1.23
    VEEV F -0.83 1.20
    BAX F 0.94 1.10
    CNMD F 0.70 1.07
    TDOC F -1.81 0.95
    HCAT F 1.31 0.89
    DNA F 8.37 0.77

    Represented by ETF Holdings

    Keywords: Medicine S&P 500 Biotechnology Cancer Lab Testing Life Sciences Nasdaq 100 Telemedicine Biopharmaceutical Telehealth Clinical Medicine Acid Biology Infectious Diseases Clinical Development Medical Technology Bone Catheter Diabetes Gene Expression
    Industries: Diagnostics & Research Biotechnology Medical Devices Medical Instruments & Supplies Health Information Services Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services Scientific & Technical Instruments Semiconductor Equipment & Materials

    Recent News for Robo Global Healthcare Technology and Innovation ETF & its Holdings

    Date Stock Title
    Jul 3 MRNA GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
    Jul 3 OMCL Omnicell (OMCL) Banks on Product Launches, Global Growth
    Jul 3 DXCM DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact
    Jul 3 MASI Masimo hits back as investment firm seeks to reselect board of directors
    Jul 3 BSX Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline
    Jul 3 VEEV Here’s Why Artisan Global Discovery Fund Trimmed Veeva Systems (VEEV)
    Jul 3 MRNA GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 MRNA Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
    Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
    Jul 3 NTRA Natera (NTRA) Soared After a 43% Increase In Revenue
    Jul 3 BDX BD to Announce Financial Results for its Third Quarter of Fiscal 2024
    Jul 3 TMO Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
    Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
    Jul 3 VCYT Market Sentiment Around Loss-Making Veracyte, Inc. (NASDAQ:VCYT)
    Jul 3 MASI Masimo employees rally around CEO Kiani as proxy fight looms
    Jul 3 SYK Should You Investigate Stryker Corporation (NYSE:SYK) At US$334?
    Jul 3 NTRA Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
    Jul 3 MRNA Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward and a Few Other Things to Know Today.
    Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
    Jul 3 NTRA Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies products and services. It is non-diversified.
    Exchange Traded Fund Index Fund Investment Management Healthcare Technology
    Back to the Main HTEC Page...